Printer Friendly
The Free Library
14,506,237 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

IVAX UK Plant Receives $6 Million Grant.


Business Editors/Health/Medical Writers

MIAMI--(BUSINESS WIRE)--July 3, 2003

IVAX Corporation IVAX Corporation was a United States public corporation focused on manufacturing and distributing generic pharmaceutical products. Ivax was acquired by the Israeli company Teva Pharmaceutical Industries in January 2006. External links
  • Ivax Pharmaceuticals homepage
 (AMEX AMEX

See: American Stock Exchange
:IVX) (LSE LSE - Language Sensitive Editor :IVX.L) announced today that its subsidiary, IVAX IVAX Industrial Vax (Dec Computer)  Pharmaceuticals UK, has received a $6 million grant to complete the construction of a $41 million manufacturing plant at Preston Brook in Cheshire, United Kingdom. The North West Development Agency's Cheshire Development Fund provided $2.8 million of the grant, and the Regional Selective Assistance, $3.3 million.

Construction of the new facility, which will greatly increase IVAX' manufacturing for its Steri-Neb(TM), injectable in·ject·a·ble
adj.
Capable of being injected. Used of a drug.

n.
A drug or medicine that can be injected.
, and ophthalmic products, is nearing completion. Because of its proximity to its present facility in nearby Runcorn - which will be closed - employees can transfer into the new plant.

Steri-Nebs are IVAX' patented nebules containing medications used for nebulizers (devices used to change liquid medications to a mist form for inhalation) to treat asthma. Nebulizers are useful for people who have difficulty using traditional inhalers - in particular, elderly, young and disabled patients. The incidence of asthma has increased over the past 20 years for all age groups, children under five being the hardest hit. Worldwide, the cost of treating asthma patients is estimated to have risen to $16 billion.

Steve Forrester-Coles, site director at IVAX Pharmaceuticals U.K., stated, "We've outgrown our two sites in Runcorn due to the rapid success of our products. It's a significant investment for the Company and a statement of confidence in its people and products. The support provided through NWDA NWDA North West Development Agency (England)
NWDA Northwest Digital Archives
NWDA National Water Development Agency (India)
NWDA National Wholesale Druggists Association
 and RSA (1) (Rural Service Area) See MSA.

(2) (Rivest-Shamir-Adleman) A highly secure cryptography method by RSA Security, Inc., Bedford, MA (www.rsa.com), a division of EMC Corporation since 2006. It uses a two-part key.
 is pivotal to the success of the whole expansion project and will secure the long term success of the business, safeguarding existing jobs and creating new opportunities."

IVAX Pharmaceuticals UK, formerly Norton Healthcare Limited, is now one of the UK's top ten pharmaceutical companies.

IVAX Corporation, headquartered in Miami, Florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.S. and internationally.

Copies of this and other news releases may be obtained free of charge from IVAX' website at http://www.ivax.com.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUUK
Date:Jul 3, 2003
Words:336
Previous Article:Horizon Bancorp Announces Further Expansion into St. Joseph, Michigan.
Next Article:Scottish Annuity & Life Holdings, Ltd. Schedules Q2 2003 Earnings Release and Conference Call for Wednesday, August 6.
Topics:



Related Articles
Prospectors receive $30-million assistance package. (Ontario provincial aid to mining industry)
IVAX To Distribute Letter to Shareholders.
IVAX PREVAILS OVER BRISTOL-MEYERS SQUIBB IN U.K. PATENT RULING.
In Response to Inquiries IVAX Confirms First to File Status on Gabapentin.
ATP Announces Merger Agreement.
IVAX Reports Increased Revenues and Net Income for 2nd Quarter of 2003; 2Q2003 Net Revenues Up 22% to $343 Million, Net Income Up 30% to $41.3...
IVAX Reports 3rd Quarter Results and Gives Guidance for 2004; IVAX Anticipates Meeting or Exceeding Consensus Estimates for 2004.
IVAX Reports Record Revenues and Increased Earnings for First Quarter of 2004 and Confirms Guidance for Y2004.
IVAX Receives Final Approval for Fluticasone Nasal Spray In UK.
ROADWORK TO ASSIST AEROSPACE INDUSTRY PLANS TO RELIEVE TRAFFIC CONGESTION ADVANCE.(News)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles